In a major step forward for the advancement of innovative therapies in the field of immunology, Sonoma Biotherapeutics has successfully raised $3,200,000 in a recent funding round. This funding underscores the growing confidence in Sonoma Biotherapeutics' pioneering work in developing engineered regulatory T cell (Treg) therapies aimed at treating serious autoimmune and inflammatory diseases that stem from imbalances within the immune system. Founded by leaders in Treg biology and cell therapy, the company is leveraging its proprietary technologies to create a new generation of targeted Treg therapies that not only aim to induce durable immune tolerance but also look to revolutionize the way these debilitating conditions are treated and prevented. With key operations based in both South San Francisco and Seattle, Sonoma Biotherapeutics is uniquely positioned to harness the vibrant biotech ecosystems in these regions. The newly acquired funds will play a critical role in advancing their research and development efforts, moving closer to the clinic with their groundbreaking therapies. This funding round not only highlights the importance of targeted cellular therapies in modern medicine but also reinforces Sonoma Biotherapeutics’ commitment to improving the lives of patients affected by autoimmune and inflammatory diseases. As the company embarks on this next pivotal stage, the team is eager to unlock the full potential of Treg therapies and contribute to a healthier future for patients worldwide.
Revolutionizing Autoimmune Treatment: Sonoma Biotherapeutics Secures $3.2 Million in Funding for Engineered Treg Therapies
Recently funded · $3.2MBiotechnology
Get the full HDAX Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
